These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16509932)

  • 21. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
    Li YF; Deng ZK; Xuan HB; Zhu JB; Ding BH; Liu XN; Chen BA
    Chin Med J (Engl); 2009 Jun; 122(12):1413-7. PubMed ID: 19567163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
    Steegmann JL; Granados E; Peñarrubia MJ
    Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
    [No Abstract]   [Full Text] [Related]  

  • 24. Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon.
    Breccia M; Diverio D; Pane F; Nanni M; Russo E; Biondo F; Frustaci A; Gentilini F; Alimena G
    Leuk Res; 2006 Dec; 30(12):1577-9. PubMed ID: 16630657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
    Volkova SA; Prytkova MV; Borovkov NN
    Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
    Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
    Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
    Denizon N; Beraud JJ; Mourad G; Blanc P; Bureau JP; Navarro M; Lavabre-Bertrand T
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1039-40. PubMed ID: 11845064
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
    Janssen JJ; Ossenkoppele GJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
    Ladoyanni E; Nambi R
    J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-alpha.
    Branford S; Hughes T; Milner A; Koelmeyer R; Schwarer A; Arthur C; Filshie R; Moreton S; Lynch K; Taylor K
    Cancer; 2007 Aug; 110(4):801-8. PubMed ID: 17607681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha.
    Steegmann JL; Requena MJ; Martín-Regueira P; De La Cámara R; Casado F; Salvanés FR; Fernández Rañada JM
    Am J Hematol; 2003 Mar; 72(3):170-6. PubMed ID: 12605388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia].
    Uehara E; Uesugi T; Tasaka T; Matsuhashi Y; Tamura T; Kuwajima M; Nagai M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):317-21. PubMed ID: 11865642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of alpha-interferon therapy in chronic myeloid leukemia].
    Udvardy M
    Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 38. Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.
    Segawa F; Shimizu Y; Saito E; Kinoshita M
    J Rheumatol; 1995 Jun; 22(6):1183-4. PubMed ID: 7674251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period.
    Giona F; Moleti ML; Del Giudice I; Testi AM; Diverio D; De Cuia MR; Mandelli F; Foa R
    Br J Haematol; 2005 Sep; 130(6):970-2. PubMed ID: 16156873
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal thrombotic microangiopathy induced by interferon-alpha.
    Badid C; McGregor B; Faivre JM; Guerard A; Juillard L; Fouque D; Laville M
    Nephrol Dial Transplant; 2001 Apr; 16(4):846-8. PubMed ID: 11274286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.